The Conference Forum Announces the Chief Medical Officer Summit, Early 2020 Keynotes and Notable Speakers

Share Article

The 8th annual Chief Medical Officer Summit will attract the largest gathering of physicians in biotech on April 6-7, 2020 in Boston. Although the program is primarily designed for CMOs of emerging biotech companies, large pharma CMOs and other R&D decision-makers also attended to exchange best practices in drug development and business management.

The Conference Forum announced the 8th annual Chief Medical Officer Summit will take place on April 6 – 7, 2020 at the Boston Marriott Cambridge in Cambridge, MA.

The Summit’s opening Keynote is the former President and CEO of Teva Pharmaceuticals, Dr Jeremy Levin. Dr Levin currently serves as CEO and Chairman of the Board of Directors at Ovid Therapeutics and Chairman of the Board at BIO. Dr Levin will draw on his vast leadership experience in vastly different settings to help physician researchers and leaders in biotech.

In a Keynote Fireside Chat, Dr Keith M Gottesdiener, CEO, Rhythm Pharmaceuticals, will share some best practices with creative FDA interactions; thoughts on leadership, culture and innovation in the changing biotech environment; and advice to CMOs in how they can best support their CEOs.

Dr Jakob Dupont, CMO of Gossamer Bio will deliver a leadership talk on his experience overseeing multiple IPOs and successful IND submissions.

Dr Akshay Vaishnaw, President of R&D at Alnylam, will deliver a Keynote Address on lessons he’s learned during his 14 years of helping grow a platform company.

Returning to the program as the Annual R&D Landscape Keynote is Ken Getz, Director of Sponsored Research, Tufts CSDD, and Founder, CISCRP. Mr Getz will present on the changing R&D landscape in the biotech and pharmaceutical industry.

Milind Kamkolkar, Chief Data Officer, Cellarity and perhaps one of the most disruptive minds in R&D will deliver the Zeitgeist presentation on the challenge of evolving a drug development organization’s data and analytics culture and capabilities.

For the first time, the CMO Summit 2020 is featuring representatives from Memorial Sloan Kettering Drug Pricing Lab, Center for the Evaluation of Value and Risk in Health (CEVR), and Patient-Driven Values in Healthcare Evaluation (PAVE) to work through the ever increasing complex pricing and reimbursement environment.

Guided by advisors, including co-chairs Dr Zain Kassam, CMO, Finch Therapeutics, Dr Julie Krop, CMO, EVP, Clinical Development & Regulatory Affairs, AMAG Pharmaceuticals Inc, and Dr Steven Zelenkofske, EVP, CMO, Achillion Pharmaceuticals, as well as Dr Beth Trehu, CMO, Jounce Therapeutics, and Dr Thomas Wessel, Independent Consultant, Berkshire Drug Development Consulting, the two-day Summit features 20+ sessions and over 35 CMO speakers.

About the Chief Medical Officer Summit
The Chief Medical Officer Summit is designed for Chief Medical Officers of emerging life science companies. The Summit addresses the challenges faced by CMOs in their multifunctional role responsible for all of R&D and many business activities. Learn more about it here.

About the Conference Forum
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. The company examines and challenges the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high-quality networking.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Allyson Adams
Follow >
Visit website